Position in ALXO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$27,365
+$859 QoQ
Shares Held
13,220
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 94 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $48,509,639 across 38 Biotechnology names. ALXO ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,347 | $22,525,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,647 | $7,262,370 | |
| 3 | INCY |
Incyte Corp
|
18,327 | $2,077,548 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
51,212 | $1,908,671 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
8,476 | $1,587,385 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,322 | $1,530,826 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,158 | $1,410,609 | |
| 8 | MRNA |
Moderna, Inc.
|
16,522 | $1,157,035 |
All Filings in ALXO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,365 | 13,220 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $26,506 | 13,220 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,938 | 13,220 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $24,192 | 13,220 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,486 | 13,220 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,236 | 13,220 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,077 | 13,220 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||